Rising to the challenges of CLE
5th December 2024
Join Professors Victoria Werth, Chris Richardson, Francois Chasset, and Ben Chong as they discuss the challenges of diagnosis, treatment, and management associated with CLE.
Rising to the challenge of inequity of outcomes in lupus treatment
10th September 2024
Join Professors Ed Vital, Vibeke Strand, Laurent Arnaud, and Guillermo Pons-Estel as they unpack the key challenges of inequities of outcomes in lupus treatment. Providing an overview of social determinants of health in SLE, the impact of race and ancestry, and controlling disease in low and middle income country populations.
Rising to the challenges of lupus trials
26th June 2024
Join Professors Ed Vital, Richard Furie, Vibeke Strand, and Brad Rovin as they unpack the modern world of lupus clinical trials; their challenges and the potential solutions.
Beyond the Guidelines, Controversies in Lupus Nephritis
16th October 2023
There are two Lupus Forum webinars in this series on Lupus nephritis. In webinar 2 Professor Ed Vital, chair of the Lupus Forum is joined by three members of the Lupus Forum steering committee, Professor Maria Dall’Era, Professor Liz Lightstone and Professor Brad Rovin The overall aim of the webinar series is to improve the understanding of the pathophysiology of lupus nephritis, the importance of early diagnosis and the challenges of management and treatment. In webinar 2 the focus is on the new and emerging therapies and how clinical practice may evolve due to these advances
Beyond the Guidelines, Controversies in Lupus Nephritis
9th October 2023
There are two Lupus Forum webinars in this series on Lupus nephritis. In webinar 1 Professor Ed Vital, chair of the Lupus Forum, is joined by two members of the Lupus Forum steering committee, Professor Maria Dall’Era and Professor Brad Rovin. The overall aim of the webinar series is to improve understanding of the pathophysiology of lupus nephritis, the importance of early diagnosis and the challenges of management and treatment. In webinar 1 the focus is on the challenges of management with standard therapies.